America’s youngest children could soon have access to two COVID-19 vaccines.
An expert panel on Wednesday unanimously found Moderna’s vaccine safe for children ages 6 months to 6 years old and provided protection against COVID-19. In a vote an hour later, the committee voted to support a Pfizer-BioNTech vaccine for children ages 6 months to 5 years.
If its decisions are upheld by the Food and Drug Administration’s commissioner and then the Centers for Disease Control and Prevention, vaccines will be available for young children as soon as Tuesday.
Views: